Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Fuisz and Boehringer Ingelheim agreement for CEFORM EA technology

June 10, 1998

U.S. patent issued covering aerosolized gene delivery using cationic lipids

June 10, 1998

Affymetrix and Human Genome Sciences to develop bacterial GeneChip probe arrays

June 10, 1998

Scriptgen and Lilly expand drug discovery collaboration

June 10, 1998

Aastrom Biosciences receives SBIR grant for dendritic cell expansion technology research

June 9, 1998

ProScript and Hoechst Marion Roussel extend antiinflammatory drug collaboration

June 8, 1998

Electroporation therapy shows promise in preclinical models of human larynx tumors

June 8, 1998

U.S. patent to be issued for vaccine delivery system

June 8, 1998

U.S. patent to be issued for cell death gene

June 4, 1998

OSI Pharmaceuticals licenses gene transcription technology to Aurora Biosciences

June 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...